Product NDC: | 0469-5201 |
Proprietary Name: | Protopic |
Non Proprietary Name: | Tacrolimus |
Active Ingredient(s): | .3 mg/g & nbsp; Tacrolimus |
Administration Route(s): | TOPICAL |
Dosage Form(s): | OINTMENT |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0469-5201 |
Labeler Name: | Astellas Pharma US Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA050777 |
Marketing Category: | NDA |
Start Marketing Date: | 20001208 |
Package NDC: | 0469-5201-02 |
Package Description: | 1 TUBE in 1 CARTON (0469-5201-02) > 2 g in 1 TUBE |
NDC Code | 0469-5201-02 |
Proprietary Name | Protopic |
Package Description | 1 TUBE in 1 CARTON (0469-5201-02) > 2 g in 1 TUBE |
Product NDC | 0469-5201 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Tacrolimus |
Dosage Form Name | OINTMENT |
Route Name | TOPICAL |
Start Marketing Date | 20001208 |
Marketing Category Name | NDA |
Labeler Name | Astellas Pharma US Inc. |
Substance Name | TACROLIMUS |
Strength Number | .3 |
Strength Unit | mg/g |
Pharmaceutical Classes | Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA] |